Medtronic's Integrity coronary stent
This article was originally published in The Gray Sheet
Executive Summary
Firm launches its Integrity bare-metal coronary stent in the U.S. following PMA supplement approval, Medtronic announces Sept. 20. The device incorporates continuous sinusoid technology paired with the firm's MicroTrac delivery system to offer improved deliverability and conformability, the company explains. Continuous sinusoid technology enables the stent to be made from a single wire. The device received CE mark clearance in February and is already available outside the U.S. Medtronic also recently received CE mark clearance for its Resolute Integrity drug-eluting coronary stent (1"The Gray Sheet" Sept. 8, 2010)